Cargando…
High Performance Integration Pipeline for Viral and Epitope Sequences
With the spread of COVID-19, sequencing laboratories started to share hundreds of sequences daily. However, the lack of a commonly agreed standard across deposition databases hindered the exploration and study of all the viral sequences collected worldwide in a practical and homogeneous way. During...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245902/ https://www.ncbi.nlm.nih.gov/pubmed/35822815 http://dx.doi.org/10.3390/biotech11010007 |
_version_ | 1784738851615408128 |
---|---|
author | Alfonsi, Tommaso Pinoli, Pietro Canakoglu, Arif |
author_facet | Alfonsi, Tommaso Pinoli, Pietro Canakoglu, Arif |
author_sort | Alfonsi, Tommaso |
collection | PubMed |
description | With the spread of COVID-19, sequencing laboratories started to share hundreds of sequences daily. However, the lack of a commonly agreed standard across deposition databases hindered the exploration and study of all the viral sequences collected worldwide in a practical and homogeneous way. During the first months of the pandemic, we developed an automatic procedure to collect, transform, and integrate viral sequences of SARS-CoV-2, MERS, SARS-CoV, Ebola, and Dengue from four major database institutions (NCBI, COG-UK, GISAID, and NMDC). This data pipeline allowed the creation of the data exploration interfaces VirusViz and EpiSurf, as well as ViruSurf, one of the largest databases of integrated viral sequences. Almost two years after the first release of the repository, the original pipeline underwent a thorough refinement process and became more efficient, scalable, and general (currently, it also includes epitopes from the IEDB). Thanks to these improvements, we constantly update and expand our integrated repository, encompassing about 9.1 million SARS-CoV-2 sequences at present (March 2022). This pipeline made it possible to design and develop fundamental resources for any researcher interested in understanding the biological mechanisms behind the viral infection. In addition, it plays a crucial role in many analytic and visualization tools, such as ViruSurf, EpiSurf, VirusViz, and VirusLab. |
format | Online Article Text |
id | pubmed-9245902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92459022022-07-06 High Performance Integration Pipeline for Viral and Epitope Sequences Alfonsi, Tommaso Pinoli, Pietro Canakoglu, Arif BioTech (Basel) Article With the spread of COVID-19, sequencing laboratories started to share hundreds of sequences daily. However, the lack of a commonly agreed standard across deposition databases hindered the exploration and study of all the viral sequences collected worldwide in a practical and homogeneous way. During the first months of the pandemic, we developed an automatic procedure to collect, transform, and integrate viral sequences of SARS-CoV-2, MERS, SARS-CoV, Ebola, and Dengue from four major database institutions (NCBI, COG-UK, GISAID, and NMDC). This data pipeline allowed the creation of the data exploration interfaces VirusViz and EpiSurf, as well as ViruSurf, one of the largest databases of integrated viral sequences. Almost two years after the first release of the repository, the original pipeline underwent a thorough refinement process and became more efficient, scalable, and general (currently, it also includes epitopes from the IEDB). Thanks to these improvements, we constantly update and expand our integrated repository, encompassing about 9.1 million SARS-CoV-2 sequences at present (March 2022). This pipeline made it possible to design and develop fundamental resources for any researcher interested in understanding the biological mechanisms behind the viral infection. In addition, it plays a crucial role in many analytic and visualization tools, such as ViruSurf, EpiSurf, VirusViz, and VirusLab. MDPI 2022-03-21 /pmc/articles/PMC9245902/ /pubmed/35822815 http://dx.doi.org/10.3390/biotech11010007 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alfonsi, Tommaso Pinoli, Pietro Canakoglu, Arif High Performance Integration Pipeline for Viral and Epitope Sequences |
title | High Performance Integration Pipeline for Viral and Epitope Sequences |
title_full | High Performance Integration Pipeline for Viral and Epitope Sequences |
title_fullStr | High Performance Integration Pipeline for Viral and Epitope Sequences |
title_full_unstemmed | High Performance Integration Pipeline for Viral and Epitope Sequences |
title_short | High Performance Integration Pipeline for Viral and Epitope Sequences |
title_sort | high performance integration pipeline for viral and epitope sequences |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245902/ https://www.ncbi.nlm.nih.gov/pubmed/35822815 http://dx.doi.org/10.3390/biotech11010007 |
work_keys_str_mv | AT alfonsitommaso highperformanceintegrationpipelineforviralandepitopesequences AT pinolipietro highperformanceintegrationpipelineforviralandepitopesequences AT canakogluarif highperformanceintegrationpipelineforviralandepitopesequences |